Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Appointed director
CC transcript
ENZO BIOCHEM INC (ENZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/11/2021 8-K Quarterly results
03/16/2021 8-K Quarterly results
12/14/2020 8-K Quarterly results
Docs: "Conference call and live webcast scheduled for today, Wednesday, December 9, 2020 at 4:30 pm"
06/08/2020 8-K Quarterly results
Docs: "Press Release of Enzo Biochem, Inc."
03/05/2020 8-K Quarterly results
12/10/2019 8-K Quarterly results
10/15/2019 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS FISCAL FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS"
06/10/2019 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS FISCAL THIRD QUARTER AND NINE MONTHS OPERATING RESULTS -------- Company Outlines Three Prong Short-Term Value Creation and Growth Strategy Intellectual Property Settlements Generate Approximately $30 Million in Cash in the Third Quarter , June 10, 2019 -- Enzo Biochem, Inc. , an integrated life sciences company focused on commercializing innovative diagnostic and therapeutics products, today reported results for the fiscal quarter and nine months ended April 30, 2019. The Company updated the market on the progress of its short-term growth and profitability initiatives designed to unlock value. Financial Results"
03/11/2019 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS SECOND FISCAL QUARTER AND FIRST HALF 2019 RESULTS AND REPORTS PROGRESS ON ITS INVESTMENTS AND STRATEGIC GOALS , March 11, 2019 -- Enzo Biochem, Inc. , an integrated diagnostics and therapeutics company, today reported results for the fiscal quarter and first half ended January 31, 2019 along with providing more detail on its investments in the development of novel diagnostic system and centralized clinical services. Recent Developments"
12/10/2018 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS FISCAL 2019 FIRST QUARTER RESULTS ------- Recent Reimbursement Cuts Emphasize Value of Enzo’ s Strategy"
10/15/2018 8-K Quarterly results
03/12/2018 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS SECOND QUARTER AND FIRST HALF RESULTS ----- Integrated Diagnostic Company Reports Higher Revenues"
12/07/2017 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS IMPROVED FIRST QUARTER RESULTS --- Clinical Labs Posts Double Digit Revenue Increase, Sharply Higher Operating Income --- Outlook Buoyed by Successful Product Developments, Especially Women’ s Health Panel"
09/27/2017 8-K Quarterly results
06/08/2017 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS INCREASED REVENUES, IMPROVED OPERATING RESULTS Clinical Labs Records Sixth Straight Quarterly Revenue Gain on Growing Molecular Diagnostics Volume New York State Approvals of New Molecular Diagnostic Assays Highlight R&D Activity",
"Enzo Biochem Announces New York State Health Department Approval of New Women’ s Health Diagnostics Underscores Enzo’ s Growing Test Menu of High Performing Molecular Diagnostics"
03/13/2017 8-K Form 8-K - Current report
12/08/2016 8-K Form 8-K - Current report
10/13/2016 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS STRONG 2016 OPERATING RESULTS -----"
06/08/2016 8-K Form 8-K - Current report
03/09/2016 8-K Form 8-K - Current report
12/07/2015 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS STRONG FIRST QUARTER Execution on Corporate Strategy seen in Company’ s Results"
10/13/2015 8-K Quarterly results
Docs: "Settlement and License Agreement between Enzo Life Sciences, Inc., and Affymetrix, Inc",
"ENZO BIOCHEM REPORTS STRONG FOURTH QUARTER RESULTS ----- Higher Revenues and Operating Income, Plus Legal Settlements, Result in Net Income Exceeding $8 Million, or 18 Cents Per Share",
"Enzo Biochem Reaches $10 Million Patent Infringement Settlement with Affymetrix, Inc."
06/09/2015 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS THIRD QUARTER RESULTS, INCLUDING STRONG REVENUE GROWTH AT CLINICAL LABS REFLECTING INCREASING VOLUME AND GREATER MOLECULAR DIAGNOSTIC ACTIVITY"
03/12/2015 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS FISCAL SECOND QUARTER RESULTS"
12/09/2014 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS STRONG FISCAL FIRST QUARTER RESULTS Operating Earnings Growth in Life Sciences and Clinical Labs"
10/09/2014 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS STRONG FISCAL FOURTH QUARTER RESULTS Transformative Programs to Heighten Efficiency, Broaden Capabilities Yield Solid Benefits"
06/12/2013 8-K Form 8-K - Current report
03/13/2013 8-K Form 8-K - Current report
12/11/2012 8-K Form 8-K - Current report
10/15/2012 8-K Quarterly results
Docs: "ENZO BIOCHEM REPORTS FOURTH QUARTER RESULTS AND ANNOUNCES REALIGNMENT PROGRAM EXPECTED TO REDUCE ANNUALIZED COSTS $6 MILLION COMMENCING WITH FISCAL FIRST QUARTER ---"
06/15/2012 8-K Form 8-K - Current report
03/14/2012 8-K Form 8-K - Current report
03/15/2011 8-K Form 8-K - Current report
12/16/2010 8-K Quarterly results
Docs: "ENZO BIOCHEM ANNOUNCES FIRST QUARTER RESULTS — COMPANY GENERATES POSITIVE EBITDA, IMPROVING $2.9 MILLION SEQUENTIALLY; RECENT ACTIONS TO STREAMLINE OPERATIONS BEGIN TO DRIVE RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy